SharpMed, LLC is proud to announce a major milestone: the Turbo® O₂ Cap has received its fourth issued patent. This latest addition strengthens our growing intellectual property portfolio and reinforces our commitment to innovation in airway management. The Turbo® O₂...
We’re thrilled to share major milestones as we push forward into commercialization! Official U.S. Launch The Turbo® O₂ Cap officially launched in the United States on March 11, 2025—a groundbreaking step for this first-of-its-kind medical device! Expanding Sales...
FOR IMMEDIATE RELEASE Phoenix, AZ – June 24, 2024 – SharpMed, LLC, a pioneer in innovative medical solutions, is thrilled to announce a strategic partnership with AMS Micromedical, a leading medical device manufacturer in the United States, to produce the...
Sharpmed, LLC is thrilled to announce it acquired a key respiratory product patent. This patent adds to the growing portfolio for our device called Turbo® O₂ Cap. “This patent is key for our strategy of becoming the future market leader for devices to...
SharpMed, LLC is pleased to announce its 2nd issued United States patent (Issued on August 31, 2021). This 2nd patent relates to our device called the RT3; which is a modern, cost-effective chest tube insertion trainer. There are a number of ways to train on chest...
